1-Step Separation System (FEOSS)

BMS is currently developing its FEOSS (Ferrofluid-Enabled One-Step Separation) system for cell separation applications for the biopharma research market.  FEOSS’ patent-pending technology revolutionizes the way in which cell separations are performed, allowing magnetically labeled target cells to be lifted right out of solution and recovered with extremely high purity (≥98%), viability (>99%) and high yields.

FEOSS isolated cells can be analyzed directly on the FEOSS collection surface, or alternatively, captured cells can be retrieved for further downstream processing.  In short, FEOSS produces better cell separation results (yield, purity, and viability) much more rapidly than competing cell separation methods with drastically less cell manipulation which translates into healthier cells for biomedical research.